{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:00:26Z","timestamp":1776099626870,"version":"3.50.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,27]]},"abstract":"<jats:p>Biliary tract infections complicated by disseminated intravascular coagulation (DIC) require urgent source control and careful correction of coagulopathy. Recombinant thrombomodulin (rTM) is widely used for DIC in Japan, but its perioperative safety in patients undergoing percutaneous transhepatic gallbladder drainage (PTGBD) has not been fully clarified. This study aims to determine whether perioperative rTM administration increases the risk of PTGBD-related adverse events (AEs) in patients with biliary tract infections and DIC. This retrospective cohort study included patients with biliary tract infections and DIC who underwent PTGBD between January 2017 and August 2025 at a single tertiary center. Patients who died within 24 hours or who initiated rTM more than 3 days after PTGBD were excluded. The primary outcome was PTGBD-related AEs. Secondary outcomes included bleeding-related AEs, 28-day mortality, DIC resolution on Day 7, and intensive care unit length of stay. Bayesian sensitivity analyses and stratified analyses based on concomitant therapies were also performed. A total of 30 patients were included (19 received rTM and 11 did not). PTGBD-related AEs occurred in 21.1% of the rTM group and 18.2% of the non-rTM group. No bleeding-related AEs were observed in either group. Bayesian analysis estimated upper 95% credible limits of 2.8% and 3.1% for PTGBD-related bleeding in the rTM and non-rTM groups, respectively. Secondary outcomes \u2013 including 28-day mortality, DIC resolution on Day 7, and intensive care unit stay \u2013 showed no meaningful differences between groups, and stratified analyses yielded consistent results. Perioperative rTM use during PTGBD was not associated with an increased incidence of PTGBD-related AEs, including bleeding. These findings indicate that rTM may be administered without substantial additional procedural risk in patients with biliary tract infections and DIC, although larger studies are needed to validate its safety.<\/jats:p>","DOI":"10.1097\/md.0000000000047869","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T01:01:26Z","timestamp":1772240486000},"page":"e47869","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Safety of recombinant thrombomodulin during percutaneous transhepatic gallbladder drainage in patients with biliary tract infections and disseminated intravascular coagulation: A retrospective cohort study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3796-3108","authenticated-orcid":false,"given":"Tetsushi","family":"Azami","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, Showa Medical University Fujigaoka Hospital, Yokohama, Kanagawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Takano","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, Showa Medical University Fujigaoka Hospital, Yokohama, Kanagawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Tamai","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, Showa Medical University Fujigaoka Hospital, Yokohama, Kanagawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, Showa Medical University Fujigaoka Hospital, Yokohama, Kanagawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitaka","family":"Niiya","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, Showa Medical University Fujigaoka Hospital, Yokohama, Kanagawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Nagahama","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, Showa Medical University Fujigaoka Hospital, Yokohama, Kanagawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260413","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jhbp.515","article-title":"Tokyo guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos).","volume":"25","author":"Yokoe","year":"2018","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R2-20260413","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.thromres.2023.05.009","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation: A meta-analysis.","volume":"226","author":"Kato","year":"2023","journal-title":"Thromb Res"},{"key":"R3-20260413","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial.","volume":"5","author":"Saito","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R4-20260413","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2017-12-768994","article-title":"Exploring traditional and nontraditional roles for thrombomodulin.","volume":"132","author":"Loghmani","year":"2018","journal-title":"Blood"},{"key":"R5-20260413","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5009\/gnl17489","article-title":"Clinical impact of recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholangitis.","volume":"12","author":"Okuda","year":"2018","journal-title":"Gut Liver"},{"key":"R6-20260413","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.thromres.2018.12.025","article-title":"Multicenter clinical experience with recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholecystitis.","volume":"176","author":"Ogura","year":"2019","journal-title":"Thromb Res"},{"key":"R7-20260413","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3748\/wjg.v21.i2.533","article-title":"Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation.","volume":"21","author":"Suetani","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R8-20260413","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1620\/tjem.252.53","article-title":"Recombinant human soluble thrombomodulin contributes to a reduction in in-hospital mortality of acute cholangitis with disseminated intravascular coagulation: a propensity score analyses of a Japanese nationwide database.","volume":"252","author":"Tarasawa","year":"2020","journal-title":"Tohoku J Exp Med"},{"key":"R9-20260413","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2019.5358","article-title":"Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial.","volume":"321","author":"Vincent","year":"2019","journal-title":"JAMA"},{"key":"R10-20260413","first-page":"e93379","article-title":"Safety of recombinant thrombomodulin for severe gastroenterological sepsis-induced coagulopathy in patients undergoing invasive digestive procedures: a single-center retrospective cohort study.","volume":"17","author":"Fujikawa","year":"2025","journal-title":"Cureus"},{"key":"R11-20260413","first-page":"e80589","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation after emergency surgery.","volume":"17","author":"Nagata","year":"2025","journal-title":"Cureus"},{"key":"R12-20260413","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"R13-20260413","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.CCM.0000202209.42491.38","article-title":"A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria.","volume":"34","author":"Gando","year":"2006","journal-title":"Crit Care Med"},{"key":"R14-20260413","first-page":"537","article-title":"Percutaneous cholecystostomy: an update for the 2020s.","volume":"8","author":"Karakas","year":"2021","journal-title":"North Clin Istanb"},{"key":"R15-20260413","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jvir.2010.01.012","article-title":"Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy.","volume":"21","author":"Saad","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"R16-20260413","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1007\/s00330-020-07368-6","article-title":"Percutaneous transhepatic biliary drainage (PTBD) in patients with dilated vs nondilated bile ducts: technical considerations and complications.","volume":"31","author":"Pedersoli","year":"2021","journal-title":"Eur Radiol"},{"key":"R17-20260413","doi-asserted-by":"crossref","first-page":"e0310469","DOI":"10.1371\/journal.pone.0310469","article-title":"Outcomes of percutaneous transhepatic gallbladder drainage versus percutaneous transhepatic biliary drainage for obstructive jaundice.","volume":"20","author":"Azami","year":"2025","journal-title":"PLoS One"},{"key":"R18-20260413","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1177\/0300060518786632","article-title":"Percutaneous cholecystostomy for biliary decompression in patients with cholangitis and pancreatitis.","volume":"46","author":"Park","year":"2018","journal-title":"J Int Med Res"},{"key":"R19-20260413","doi-asserted-by":"crossref","first-page":"e0735","DOI":"10.1097\/MD.0000000000010735","article-title":"Percutaneous cholecystostomy for high-risk patients with acute cholangitis.","volume":"97","author":"Li","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"R20-20260413","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5754\/hge11424","article-title":"Percutaneous transhepatic cholecystostomy for choledocholithiasis with acute cholangitis in high-risk patients.","volume":"59","author":"Ren","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"R21-20260413","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1007\/s00261-020-02898-5","article-title":"Alternative application of percutaneous cholecystostomy in patients with biliary obstruction.","volume":"46","author":"Chung","year":"2021","journal-title":"Abdom Radiol (NY)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047869","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T16:01:47Z","timestamp":1776096107000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047869","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"2025-12-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}